Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Liafensine by Denovo Biopharma for Treatment Resistant Depression: Likelihood of Approval
Liafensine is under clinical development by Denovo Biopharma and currently in Phase II for Treatment Resistant Depression. According to GlobalData,...